As the 340B Rebate Model Pilot approaches, hospitals and health systems are preparing for one of the most significant shifts the program has faced in years. In this episode, Jim Jorgensen is joined by Kristin Fox-Smith, Managing Director, and Jerame Hill, Chief Strategy Officer at Visante, to break down what the new rebate model means for covered entities.
 
This conversation is especially important for hospital executives as the rebate model directly impacts cash flow, staffing needs, operational risk, and financial planning. The group discusses the real-world implications of HRSA’s guidance, including increased data and reconciliation complexity, ongoing uncertainty as January 1 approaches, and the decisions leaders may soon face. Listeners will also hear practical insight on how to prepare now to reduce risk and protect organizational performance.

Pharmacy Innovators Podcast

Visante Consulting

340B Rebate Readiness: What Covered Entities Need to Know Now

DEC 17, 202528 MIN
Pharmacy Innovators Podcast

340B Rebate Readiness: What Covered Entities Need to Know Now

DEC 17, 202528 MIN

Description

As the 340B Rebate Model Pilot approaches, hospitals and health systems are preparing for one of the most significant shifts the program has faced in years. In this episode, Jim Jorgensen is joined by Kristin Fox-Smith, Managing Director, and Jerame Hill, Chief Strategy Officer at Visante, to break down what the new rebate model means for covered entities.   This conversation is especially important for hospital executives as the rebate model directly impacts cash flow, staffing needs, operational risk, and financial planning. The group discusses the real-world implications of HRSA’s guidance, including increased data and reconciliation complexity, ongoing uncertainty as January 1 approaches, and the decisions leaders may soon face. Listeners will also hear practical insight on how to prepare now to reduce risk and protect organizational performance.